Experimental virus therapy takes on Drug-Resistant cancers
Disease control
Not yet recruiting
This early-stage trial tests a new cancer treatment called OTS-412, a modified virus designed to attack tumor cells. It is given alone or with hydroxyurea and the immunotherapy atezolizumab. The study includes 24 adults with advanced solid tumors that no longer respond to standar…
Phase: PHASE1 • Sponsor: Bionoxx Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC